n2n presentation
Post on 14-Jan-2016
4 Views
Preview:
DESCRIPTION
TRANSCRIPT
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 1/69
Next to NormalA Dramaturgical Presentation
by Matthew Silar
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 2/69
From humble beginnings...
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 3/69
From humble beginnings...
Feeling Electric began as a 10 minute musical
submission for the BMI Lehman Engel Musical
Theatre Workshop in 1998. Yorkey pitched the
idea to Kitt and they collaborated.
The idea was scrapped until 2002 when the full
length premiered at the Village Theatre in
Washington.
In 2005, the Village picked it up again which led to
a performance at NYMF. It was at NYMF that
producer David Stone picked up the project.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 4/69
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 5/69
Second Stage workshopped the show twice, once
in 2006, once in 2007.
It o!cially hit O"-Broadway on January 16, 2008.
Next to Normal went back to a regional setting at
the Arena Stage from November 21, 2008 to
January 18, 2009.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 6/69
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 7/69
Opened on Broadway on April 15, 2009
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 8/69
Opened on Broadway on April 15, 2009
Closed on January 16, 2011
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 9/69
Opened on Broadway on April 15, 2009
Closed on January 16, 2011
773 performances
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 10/69
Congratulations!
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 11/69
Brave and breathtaking- Ben Brantly
Congratulations!
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 12/69
Brave and breathtaking- Ben Brantly
Agonizingly Beautiful- Entertainment Weekly
Congratulations!
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 13/69
Brave and breathtaking- Ben Brantly
Agonizingly Beautiful- Entertainment Weekly
The future of American Musicals- The Washington
Post
Congratulations!
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 14/69
Brave and breathtaking- Ben Brantly
Agonizingly Beautiful- Entertainment Weekly
The future of American Musicals- The Washington
Post
The best musical of the season, by a mile!- Rolling
Stone Magazine
Congratulations!
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 15/69
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 16/69
Pulitzer Prize - Drama
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 17/69
Pulitzer Prize - Drama
Tony Award- Original Score
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 18/69
Pulitzer Prize - Drama
Tony Award- Original Score
Tony Award- Best Performance by a Leading
Actress in a Musical (Alice Ripley)
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 19/69
Pulitzer Prize - Drama
Tony Award- Original Score
Tony Award- Best Performance by a Leading
Actress in a Musical (Alice Ripley)
Tony Award- Best Orchestrations
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 20/69
Pulitzer Prize - Drama
Tony Award- Original Score
Tony Award- Best Performance by a Leading
Actress in a Musical (Alice Ripley)
Tony Award- Best Orchestrations
Helen Hayes- Outstanding Lead Actress (Alice
Ripley)
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 21/69
Pulitzer Prize - Drama
Tony Award- Original Score
Tony Award- Best Performance by a Leading
Actress in a Musical (Alice Ripley)
Tony Award- Best Orchestrations
Helen Hayes- Outstanding Lead Actress (Alice
Ripley)
Helen Hayes- Outstanding Supporting Performer
(J. Robert Spencer)
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 22/69
That’s right, you’re doing a
musical that discusses...
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 23/69
Mental Health
Medicinal Drug Use
Recreational Drug Use
Premarital Sex
Strong Language
Suicide
Depression
ECT, one of the most
controversial medicalpractices to this day
Dysfunctional family
structures
Marital Separation
That’s right, you’re doing a
musical that discusses...
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 24/69
What are you?INSANE?
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 25/69
For God gave us a spirit not of fear but of power
and love and self-control.- 2 Timothy 1:7
Fear not, for I am with you; be not dismayed, for I
am your God; I will strengthen you, I will help you,
I will uphold you with my righteous right hand.-
Isaiah 41:10
When the righteous cry for help, the Lord hears
and delivers them out of all their troubles. The
Lord is near to the brokenhearted and saves the
crushed in spirit. Many are the a#ictions of the
righteous, but the Lord delivers him out of them
all. He keeps all his bones; not one of them is
broken.- Psalm 34:17-20
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 26/69
Bipolar Depression
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 27/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 28/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
Bipolar Disorder Type 1
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 29/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
Bipolar Disorder Type 1
manic depression (Diana)
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 30/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
Bipolar Disorder Type 1
manic depression (Diana)
Bipolar Disorder Type 2
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 31/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
Bipolar Disorder Type 1
manic depression (Diana)
Bipolar Disorder Type 2
cyclothymia
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 32/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
Bipolar Disorder Type 1
manic depression (Diana)
Bipolar Disorder Type 2
cyclothymia
hypomania and mild
depression
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 33/69
Bipolar DepressionBipolar Disorder is a condition in which an individual goes
back and forth between positive and manic moods and/ or a state of depression.
Bipolar Disorder Type 1
manic depression (Diana)
Bipolar Disorder Type 2
cyclothymia
hypomania and mild
depression
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 34/69
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 35/69
Bipolar Disorder a"ects between 2 and 3 percent ofthe population.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 36/69
There is no known cure orcause.
Bipolar Disorder a"ects between 2 and 3 percent ofthe population.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 37/69
There is no known cure orcause.
Hereditary
Bipolar Disorder a"ects between 2 and 3 percent ofthe population.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 38/69
There is no known cure orcause.
Hereditary
Severe episodes of maniaor depression can lead topsychosis. (detachmentfrom reality)
Bipolar Disorder a"ects between 2 and 3 percent ofthe population.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 39/69
There is no known cure orcause.
Hereditary
Severe episodes of maniaor depression can lead topsychosis. (detachmentfrom reality)
hallucinations
Bipolar Disorder a"ects between 2 and 3 percent ofthe population.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 40/69
There is no known cure orcause.
Hereditary
Severe episodes of maniaor depression can lead topsychosis. (detachmentfrom reality)
hallucinations
delusions
Bipolar Disorder a"ects between 2 and 3 percent ofthe population.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 41/69
Treatment Options
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 42/69
Mood Stabilizing Drugs
Treatment Options
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 43/69
Mood Stabilizing Drugs
Lithium and anticonvulsants (Depakote)
Treatment Options
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 44/69
Mood Stabilizing Drugs
Lithium and anticonvulsants (Depakote)
Psychotherapy
Treatment Options
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 45/69
Mood Stabilizing Drugs
Lithium and anticonvulsants (Depakote)
Psychotherapy
Talk Therapy
Treatment Options
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 46/69
Mood Stabilizing Drugs
Lithium and anticonvulsants (Depakote)
Psychotherapy
Talk Therapy
Cognitive, Interpersonal, Family-Focused
Treatment Options
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 47/69
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 48/69
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 49/69
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 50/69
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICAL
SYMPTOMS.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 51/69
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICAL
SYMPTOMS.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
XANAX (ALPRAZOLAM) BELONGS TO A GROUP OF DRUGS CALLED
BENZODIAZEPINES. IT WORKS BY SLOWING DOWN THE MOVEMENT OFCHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED. THIS RESULTS IN
A REDUCTION IN NERVOUS TENSION (ANXIETY)
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 52/69
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICAL
SYMPTOMS.
DEPAKOTE (DIVALPROEX) IS A ANTI-CONVULSANT. IT IS USUALLY PRESCRIBED FOR PERSONS WHO ARE BIPOLAR (MANIC
DEPRESSIVE), OR A SIMILAR ILLNESS. IT IS SOMETIMES PRESCRIBED FOR PEOPLE WHO EXPERIENCE CHRONIC MIGRAINE HEADACHES.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
XANAX (ALPRAZOLAM) BELONGS TO A GROUP OF DRUGS CALLED
BENZODIAZEPINES. IT WORKS BY SLOWING DOWN THE MOVEMENT OFCHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED. THIS RESULTS IN
A REDUCTION IN NERVOUS TENSION (ANXIETY)
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 53/69
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICAL
SYMPTOMS.
DEPAKOTE (DIVALPROEX) IS A ANTI-CONVULSANT. IT IS USUALLY PRESCRIBED FOR PERSONS WHO ARE BIPOLAR (MANIC
DEPRESSIVE), OR A SIMILAR ILLNESS. IT IS SOMETIMES PRESCRIBED FOR PEOPLE WHO EXPERIENCE CHRONIC MIGRAINE HEADACHES.
KLONOPIN (CLONAZEPAM) IS IN A GROUP OF DRUGS CALLED BENZODIAZEPINES (BEN-ZOE-DYE-AZE-EH-PEENS_/ CLONAZEPAM
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND CAUSE ANXIETY.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
XANAX (ALPRAZOLAM) BELONGS TO A GROUP OF DRUGS CALLED
BENZODIAZEPINES. IT WORKS BY SLOWING DOWN THE MOVEMENT OFCHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED. THIS RESULTS IN
A REDUCTION IN NERVOUS TENSION (ANXIETY)
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
AMBIEN (ZOLPIDEM) IS A SEDATIVE ALSO CALLED A HYPNOTIC IT AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 54/69
AMBIEN (ZOLPIDEM) IS A SEDATIVE, ALSO CALLED A HYPNOTIC. IT AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME
UNBALANCED AND CAUSE SLEEP PROBLEMS (INSOMNIA).
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICAL
SYMPTOMS.
DEPAKOTE (DIVALPROEX) IS A ANTI-CONVULSANT. IT IS USUALLY PRESCRIBED FOR PERSONS WHO ARE BIPOLAR (MANIC
DEPRESSIVE), OR A SIMILAR ILLNESS. IT IS SOMETIMES PRESCRIBED FOR PEOPLE WHO EXPERIENCE CHRONIC MIGRAINE HEADACHES.
KLONOPIN (CLONAZEPAM) IS IN A GROUP OF DRUGS CALLED BENZODIAZEPINES (BEN-ZOE-DYE-AZE-EH-PEENS_/ CLONAZEPAM
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND CAUSE ANXIETY.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
XANAX (ALPRAZOLAM) BELONGS TO A GROUP OF DRUGS CALLED
BENZODIAZEPINES. IT WORKS BY SLOWING DOWN THE MOVEMENT OFCHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED. THIS RESULTS IN
A REDUCTION IN NERVOUS TENSION (ANXIETY)
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
AMBIEN (ZOLPIDEM) IS A SEDATIVE ALSO CALLED A HYPNOTIC IT AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 55/69
AMBIEN (ZOLPIDEM) IS A SEDATIVE, ALSO CALLED A HYPNOTIC. IT AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME
UNBALANCED AND CAUSE SLEEP PROBLEMS (INSOMNIA).
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICALSYMPTOMS.
DEPAKOTE (DIVALPROEX) IS A ANTI-CONVULSANT. IT IS USUALLY PRESCRIBED FOR PERSONS WHO ARE BIPOLAR (MANIC
DEPRESSIVE), OR A SIMILAR ILLNESS. IT IS SOMETIMES PRESCRIBED FOR PEOPLE WHO EXPERIENCE CHRONIC MIGRAINE HEADACHES.
KLONOPIN (CLONAZEPAM) IS IN A GROUP OF DRUGS CALLED BENZODIAZEPINES (BEN-ZOE-DYE-AZE-EH-PEENS_/ CLONAZEPAM
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND CAUSE ANXIETY.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
PROZAC (FLUOXETINE) IS A SELECTIVE SEROTONIN REUPTAKE
INHIBITORS (SSRI) ANTIDEPRESSANT. PROZAC AFFECTS CHEMICALS IN THE
BRAIN THAT MAY BECOME UNBALANCED AND CAUSE DEPRESSION, PANIC,
ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS.
XANAX (ALPRAZOLAM) BELONGS TO A GROUP OF DRUGS CALLED
BENZODIAZEPINES. IT WORKS BY SLOWING DOWN THE MOVEMENT OFCHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED. THIS RESULTS IN
A REDUCTION IN NERVOUS TENSION (ANXIETY)
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
AMBIEN (ZOLPIDEM) IS A SEDATIVE ALSO CALLED A HYPNOTIC IT AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 56/69
AMBIEN (ZOLPIDEM) IS A SEDATIVE, ALSO CALLED A HYPNOTIC. IT AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME
UNBALANCED AND CAUSE SLEEP PROBLEMS (INSOMNIA).
ATIVAN (LORAZEPAM) IS IN A CLASS OF MEDICATIONS CALLED BENZODIAZEPINES. IT IS USED TO RELIEVE ANXIETY. IT WORKS BY
SLOWING ACTIVITY IN THE BRAIN TO ALLOW FOR RELAXATION.
BUSPAR (BUPIRONE) IS AN ANXIOLYTIC PSYCHOACTIVE DRUG OF THE AZAPIRONE CHEMICAL CLASS THAT IS USED TO TREAT
ANXIETY DISORDERS, HELPING TO ALLEVIATE FEAR, TENSION, IRRITABILITY, DIZZINESS, POUNDING HEARTBEAT, AND OTHER PHYSICALSYMPTOMS.
DEPAKOTE (DIVALPROEX) IS A ANTI-CONVULSANT. IT IS USUALLY PRESCRIBED FOR PERSONS WHO ARE BIPOLAR (MANIC
DEPRESSIVE), OR A SIMILAR ILLNESS. IT IS SOMETIMES PRESCRIBED FOR PEOPLE WHO EXPERIENCE CHRONIC MIGRAINE HEADACHES.
KLONOPIN (CLONAZEPAM) IS IN A GROUP OF DRUGS CALLED BENZODIAZEPINES (BEN-ZOE-DYE-AZE-EH-PEENS_/ CLONAZEPAM
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND CAUSE ANXIETY.
PAXIL (PAROXETINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIS). PAXIL AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED.
PROZAC (FLUOXETINE) IS A SELECTIVE SEROTONIN REUPTAKE
INHIBITORS (SSRI) ANTIDEPRESSANT. PROZAC AFFECTS CHEMICALS IN THE
BRAIN THAT MAY BECOME UNBALANCED AND CAUSE DEPRESSION, PANIC,
ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS.
XANAX (ALPRAZOLAM) BELONGS TO A GROUP OF DRUGS CALLED
BENZODIAZEPINES. IT WORKS BY SLOWING DOWN THE MOVEMENT OFCHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED. THIS RESULTS IN
A REDUCTION IN NERVOUS TENSION (ANXIETY)
ZOLOFT (SERTRALINE) IS AN ANTIDEPRESSANT IN A GROUP OF DRUGS
CALLED SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS). ZOLOFT
AFFECTS CHEMICALS IN THE BRAIN THAT MAY BECOME UNBALANCED AND
CAUSE DEPRESSION, PANIC, ANXIETY, OR OBSESSIVE-COMPULSIVE SYMPTOMS
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 57/69
Electroconvulsive Therapy
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 58/69
Electroconvulsive Therapy
Electric currents are applied to the head to inducesmall seizures.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 59/69
Electroconvulsive Therapy
Electric currents are applied to the head to inducesmall seizures.
Began in Italy in 1930.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 60/69
Electroconvulsive Therapy
Electric currents are applied to the head to inducesmall seizures.
Began in Italy in 1930.
In theory, ECT alters the way in which the brainresponds to chemical signals.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 61/69
Electroconvulsive Therapy
Electric currents are applied to the head to inducesmall seizures.
Began in Italy in 1930.
In theory, ECT alters the way in which the brainresponds to chemical signals.
Short term VS long term results
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 62/69
Electroconvulsive Therapy
Electric currents are applied to the head to inducesmall seizures.
Began in Italy in 1930.
In theory, ECT alters the way in which the brainresponds to chemical signals.
Short term VS long term results
Side e"ects: memory loss, disorientation,headaches, sti"ness, confusion.
El l i Th
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 63/69
Electroconvulsive Therapy
Electric currents are applied to the head to inducesmall seizures.
Began in Italy in 1930.
In theory, ECT alters the way in which the brainresponds to chemical signals.
Short term VS long term results
Side e"ects: memory loss, disorientation,headaches, sti"ness, confusion.
Fatal in about 1 in every 1,000 patients.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 64/69
Female Hysteria
F l H i
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 65/69
Female Hysteria
Greek- Medea.
Shakespeare- Hamlet
Modern- Who’s Afraid of Virginia Woolf?
Victorian Era
womb disease
An 1859 study showed 25% of women su"erfrom hysteria.
Chronic- treated but not cured.
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 66/69
Recreational Drugs
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 67/69
Recreational Drugs
2006- 1 in 5 teens reported abusing prescriptiondrugs.
2012- 1 in 4 teens reported abusing prescription
drugs.
5 million teens.
1 in 4 teens claimed their parents approved of Rx
drugs over illegal drugs.
1 in 8 teens report misusing Rx drugs such as
Ritalin and Adderall (stimulants)
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 68/69
Additional Facts
Twitter Performance
7/18/2019 N2N Presentation
http://slidepdf.com/reader/full/n2n-presentation 69/69
top related